Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Everus Construction Group, Inc. When Issued | ECG | Nov 25, 2024 | 63.91 | 0.00 |
EVgo | EVGO | Nov 25, 2024 | 6.58 | +3.46 |
EVI Industries | EVI | Nov 25, 2024 | 19.28 | -3.98 |
Evogene | EVGN | Nov 25, 2024 | 1.67 | +3.09 |
Evoke Pharma | EVOK | Nov 25, 2024 | 4.35 | +0.46 |
Evolent Health A | EVH | Nov 25, 2024 | 12.21 | +8.53 |
Evolus | EOLS | Nov 25, 2024 | 12.67 | +0.56 |
Evolution Petroleum | EPM | Nov 25, 2024 | 5.86 | -3.93 |
Evolv Technologies A | EVLV | Nov 25, 2024 | 3.36 | +8.74 |
Evotec ADR | EVO | Nov 25, 2024 | 4.89 | +8.91 |
Exact Sciences | EXAS | Nov 25, 2024 | 55.14 | +4.21 |
Exagen | XGN | Nov 25, 2024 | 4.05 | -1.22 |
Excelerate Energy | EE | Nov 25, 2024 | 30.08 | -1.60 |
ExcelFin Acquisition A | XFIN | Nov 25, 2024 | 9.24 | 0.00 |
Exela Technologies | XELA | Nov 25, 2024 | 1.98 | 0.00 |
Exela Technologies B Pref | XELAP | Nov 25, 2024 | 1.23 | 0.00 |
Exelixis | EXEL | Nov 25, 2024 | 36.38 | +2.16 |
Exelon | EXC | Nov 25, 2024 | 39.13 | +1.09 |
Exicure | XCUR | Nov 25, 2024 | 26.74 | +45.48 |
ExlService | EXLS | Nov 25, 2024 | 46.77 | +1.21 |
eXp World | EXPI | Nov 25, 2024 | 14.39 | +2.38 |
Expand Energy | EXE | Nov 25, 2024 | 98.87 | 0.00 |
Expedia | EXPE | Nov 25, 2024 | 184.08 | -0.45 |
Expeditors International of Washington | EXPD | Nov 25, 2024 | 122.39 | +0.88 |
Expensify A | EXFY | Nov 25, 2024 | 3.27 | -3.82 |
Expion360 | XPON | Nov 25, 2024 | 2.37 | -3.27 |
Exponent | EXPO | Nov 25, 2024 | 100.30 | +2.31 |
Expro | XPRO | Nov 25, 2024 | 13.86 | +0.43 |
Exscientia ADR | EXAI | Nov 25, 2024 | 4.84 | 0.00 |
Extended Dur Trs Idx ETF Vanguard | EDV | Nov 25, 2024 | 73.74 | +3.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.